Adult Type 1
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
New rapid acting meal time Insulin to treat Type 1 Diabetes
Study Length: 65 Weeks
Target Age/Sex: 18+, Male and Female
Participants will receive at no cost: Study medication, study related supplies, study related lab work and medical exams. Subject will also receive a stipend for time/travel related to the study.